Antibody Detection and Monitoring Assays

Our collection of integrated solutions allows for the determination of antibody profiles and expanded antigen coverage to give you robust results, pre and post transplant.

Most popular antibody detection and monitoring products

LABScreen assays

C1qScreen assay

One Lambda MagSort

Explore our antibody detection and monitoring products

LABScreen assays

Antibody screening, identification, and monitoring utilizing Luminex xMAP technology, to provide a complete testing solution to detect donor-specific antibodies (DSA), pre and post-transplant.

C1qScreen assay

Driven by the Luminex xMAP platform, our C1qScreen assay provides laboratories with a reliable tool for distinguishing between complement binding and non-complement binding antibodies.

FlowDSA-XM assay

A flow cytometry-based crossmatch assay optimized for the detection of leukocyte antibodies, combining traditional flow cytometry cellular crossmatch testing with the specificity of microbeads technology.

FlowPRA assays

Designed for use in flow cytometric detection, several FlowPRA test options are available to screen human sera for antibodies, assigning percent PRA and antibody specificity for HLA Class I and Class II.

One Lambda MagSort

Isolates specific HLA antibodies using magnetic bead panels to adsorb and elute targeted antibodies.

AT1R and ETAR assays

Anti-AT1R and anti-ETAR assays detect biomarker antibodies that form against angiotensin II type 1 receptors (AT1R) and endothelin receptors type A (ETAR).

Lambda Cell Trays (LCT)

Panels frozen lymphocytes dispensed in Terasaki trays, designed to determine PRA and HLA antibody screening by complement-dependent cytotoxicity.

Lambda Antigen Trays (LAT)

Economical and convenient for screening patients, determining percent PRA and identifying antibodies. Terasaki trays are pre-coated with HLA Class I and Class II antigens designed to perform antibody detection based on ELISA techniques.


Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.